M4MM
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – It's been another fortnight, and the numbers, the deals, and the science keep telling the same story: the Cannabis & Psychedelics space is not slowing down. A few from the MSOs pack ...
Trulieve Reports Q4 and FY 2025 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp., the largest U.S. Cannabis retailer by store count, announced its full-year 2025 revenue of $1.2 billion, holding steady from the previous year as retail pricing pressures offset gains from new ...
Curaleaf Reports Q4 and FY 2025 Financial Results
NEW YORK – Curaleaf Holdings Inc. released its earnings for the fourth quarter and full year ended December 31, 2025, highlighting a return to top-line growth and steady margins in a tough domestic environment. The ...
Curaleaf Reports Q4 and FY 2025 Financial Results
NEW YORK – Curaleaf Holdings Inc. released its earnings for the fourth quarter and full year ended December 31, 2025, highlighting a return to top-line growth and steady margins in a tough domestic environment. The ...
DOJ Urges SCOTUS to Ban Cannabis Consumers from Owning Guns
WASHINGTON, D.C. –The U.S. Department of Justice is strongly urging the Supreme Court to uphold a federal rule that bars Cannabis consumers from legally owning or purchasing firearms. In a brief filed with the Court, ...
GTI Reports Q4 and FY 2025 Financial Results
CHICAGO – Green Thumb Industries Inc. released its fourth-quarter and full-year 2025 earnings, showing revenue growth that outpaced the prior period even as pricing pressures continued to squeeze profitability metrics across its operations. The Chicago-based ...
Psychedelic Alpha Released Q1 2026 Psychedelic Drug Development Bullseye Charts
LOS ANGELES – Psychedelic Alpha, the data-focused research and analysis group that monitors the psychedelics sector, published its latest Bullseye Charts showing the state of drug development programs as of the first quarter of 2026. ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – It's been another fortnight, and the numbers, the deals, and the science keep telling the same story: the Cannabis & Psychedelics space is not slowing down. A few from the MSOs pack ...
Trulieve Reports Q4 and FY 2025 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp., the largest U.S. Cannabis retailer by store count, announced its full-year 2025 revenue of $1.2 billion, holding steady from the previous year as retail pricing pressures offset gains from new ...
Curaleaf Reports Q4 and FY 2025 Financial Results
NEW YORK – Curaleaf Holdings Inc. released its earnings for the fourth quarter and full year ended December 31, 2025, highlighting a return to top-line growth and steady margins in a tough domestic environment. The ...
What is Cannabis 3.0? From Brand Expansion to Platform Discipline
LOS ANGELES- If Cannabis 1.0 was legalization and survival, and Cannabis 2.0 was scale and brand proliferation, Cannabis 3.0 is something far more structural. It is the shift from product velocity to process discipline. From ...
Organigram Strikes Deal to Acquire Sanity Group
TORONTO-BERLIN – Organigram Global Inc. has signed a definitive agreement to purchase the remaining shares of Berlin-based Sanity Group GmbH that it does not already hold. The transaction builds on Organigram's earlier minority stake and ...
Innovia Consulting Acquires 365 Cannabis
ONALASKA – Innovia Consulting, a longtime provider of Microsoft Dynamics 365 Business Central services, has acquired 365 Cannabis along with its sister entity 365Vertical. The deal brings in two Microsoft partners that focus on customized ...
New 2026 Farm Bill Draft Targets Industrial Hemp Burdens
WASHINGTON – House Agriculture Committee Chairman Glenn Thompson (R-PA) introduced a new Farm Bill draft (Farm, Food, and National Security Act of 2026), proposing changes that would ease certain federal requirements for industrial hemp growers. ...
Compass Pathways Advances in Second Phase 3 Trial for Psilocybin-Assisted TRD
LONDON – Compass Pathways PLC ADR, a UK-based mental health biotech company, announced that its second Phase 3 trial met the primary endpoint in evaluating COMP360, a synthetic formulation of psilocybin, for treatment-resistant depression (TRD). ...
350 Retail Cap and Tier V Cultivation Limits: What Virginia’s Scarcity Model Means for License Strategy
RICHMOND- Virginia’s adult-use design is built on scarcity and structural oversight. The 350 retail cap materially limits market density, shaping site selection and long-term valuation models. Tier V cultivation remains limited to five large operators. ...
Virginia Adult-Use Applications Expected in 2026: Operators Should Begin Structuring Now
NEW YORK- Virginia’s adult-use Cannabis legislation is now in reconciliation after both the House (HB 642) and Senate (SB 542) advanced competing sales frameworks. For operators, the question is no longer whether retail will launch—but ...
SAM in Action: How Dark Money Fuels Prohibitionists Attacks
LOS ANGELES – A noticeable uptick in anti-Cannabis content has appeared on social platforms lately, flooding threads with posts on scromiting, schizophrenia, psychosis risks, outdated research, recycled study headlines, and new ballot proposals surfacing in ...
CMS Finalizes Rule for Medicare CBD Coverage Pilot
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) has finalized regulations enabling a pilot program for federal health insurance coverage of hemp-derived CBD products, according to a recent statement from an executive at ...
Missouri Cannabis Sales Hit Record $1.5B in 2025
JEFFERSON CITY – Missouri's regulated Cannabis market posted its strongest year yet in 2025, with retailers recording approximately $1.5 billion in total sales, according to figures from the Missouri Department of Health and Senior Services. ...
New Hampshire House Advances Bill to Regulate Medical Psilocybin Use
CONCORD – The New Hampshire House of Representatives has given initial approval to a bipartisan measure that would establish a state program allowing supervised therapeutic access to psilocybin for qualifying medical conditions. House Bill 1809, ...
As November Looms, the Intoxicating Hemp Industry Carries On — Calmly, Confidently, and Perhaps Optimistically
NEW YORK - Across the United States, the intoxicating hemp sector is behaving as though November 2026 is just another month on the calendar — not a potential regulatory cliff. That’s when new federal restrictions, ...
OPINION: The Cannabis Industry That Left Black America Behind
LOS ANGELES- America’s legal Cannabis industry loves to tell a redemption story: a plant once criminalized is now regulated, normalized, and generating billions in tax revenue. But redemption for whom? Black History Month shouldn’t just ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The Cannabis and Psychedelics sectors remain in a state of flux, balancing regulatory progress, market milestones, and corporate maneuvers with persistent challenges. Mature markets posted impressive revenue numbers, major operators strengthened their ...
AULV Health Announces U.S. Launch to Advance Integrative Health and Longevity Innovation
LOS ANGELES — Feb. 11, 2026 — AULV (Australian Longevity Vitality), an integrative health and botanical therapeutics platform founded in Australia, today announced its official launch in the United States, establishing its U.S. headquarters in ...
